Your email has been successfully added to our mailing list.

×
0 0.000314960629921225 0.0105511811023623 0.0113779527559056 0.00393700787401584 0 -0.00393700787401566 -0.015
Stock impact report

Vtv Therapeutics debuts on Nasdaq Capital, shares down 12% [Seeking Alpha]

vTv Therapeutics Inc. - Class A (VTVT) 
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vtvtherapeutics.com
Company Research Source: Seeking Alpha
Today is the first day of trading on the Nasdaq Capital Market for vTv Therapeutics ( VTVT ). Shares are down on below-average volume. The stock was previously listed on Nasdaq Global but failed to maintain the listing requirement for minimum market value. See all stocks on the move » Now read: Daxor up 29% on positive data supporting use of BVA-100 analyzer » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
VTVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VTVT alerts
Opt-in for
VTVT alerts

from News Quantified
Opt-in for
VTVT alerts

from News Quantified